Monday 10 September 2018

Reuters Health Report: Merck's Keytruda clocks up new win as EU approves chemo cocktail

Reuters.com Newsletter

Merck's Keytruda clocks up new win as EU approves chemo cocktail

Merck & Co's key cancer drug Keytruda has been approved for use in Europe in combination with chemotherapy in previously untreated lung cancer patients, marking a further advance for the product after uncertainty about its EU prospects a year ago.

Consort, Opiant to develop nasal spray for opioid overdose treatment

Britain's Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc.

Ebola fight has new science but faces old hurdles in restive Congo

When Esperance Nzavaki heard she was cured of Ebola after three weeks of cutting-edge care at a medical center in eastern Democratic Republic of Congo, she raised her arms to the sky with joy and praised the Lord.

Roche faces UK pricing row over multiple sclerosis drug Ocrevus

Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).

Cholera outbreak kills 10 people in Zimbabwe

A cholera outbreak has killed 10 people in Zimbabwe's capital Harare after they drank contaminated water, a city health official said on Sunday.

Japan finds first swine fever case in 26 years, but not African fever

Japan's agriculture ministry said on Sunday it had confirmed the country's first outbreak of swine fever in 26 years and suspended exports of pork and wild boar meat.

South Korean man infected by MERS virus, first case in 3 years

A South Korean man, 61, was diagnosed with the potentially deadly Middle East Respiratory Syndrome (MERS) and is being treated at a hospital in Seoul, the Korea Centers for Disease Control and Prevention (KCDC) said on Saturday.

Two health scares at U.S. airports tied to Mecca pilgrims: U.S. officials

Two major health scares at U.S. airports involving inbound flights are related to pilgrims returning from the Hajj, the Muslim pilgrimage to the holy city of Mecca, Saudi Arabia, which ended in late August, U.S. health officials said on Friday.

GSK says U.S. FDA wants more information on pulmonary drug

GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD).

Youth soccer injury prevention program saves healthcare costs

(Reuters Health) - An injury prevention program tailored to children's soccer is not only more effective than typical warmups and stretches at keeping players safe, it's also associated with lower healthcare costs, a Swiss study suggests.

HIV prevention pill reaching more people who need it

(Reuters Health) - More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS